Hirudal Cream contains Mucopolysaccharide Polysulfate (250 IU/gm) as its active ingredient, a potent anticoagulant and anti-inflammatory agent used topically to manage various vascular and inflammatory conditions. This cream is primarily indicated for the treatment of superficial thrombophlebitis, hematomas, bruises, and localized inflammatory processes associated with trauma or surgery. Mucopolysaccharide Polysulfate acts by inhibiting thrombin activity and promoting fibrinolysis, thereby facilitating the dissolution of blood clots and improving microcirculation. Additionally, it exhibits anti-edematous properties that help reduce swelling and pain in affected tissues. Hirudal Cream is applied directly to the affected area, allowing localized therapeutic effects with minimal systemic absorption, reducing the risk of systemic anticoagulation and related adverse effects. It is generally well tolerated; however, caution is advised in patients with bleeding disorders or those receiving systemic anticoagulant therapy. The cream should be used as directed by a healthcare professional, typically applied two to three times daily, and treatment duration depends on the severity and nature of the condition. Avoid contact with mucous membranes and broken skin. Hirudal Cream offers an effective topical option for managing conditions involving superficial thrombosis and inflammation, promoting faster recovery and symptom relief.